Table 1 IgG ELISA results to P0, P2 and PMP22
nT-CIDP (total n = 18)T-CIDP (total n = 12)HC (total n = 32)CIAP (total n = 25)p Value
P030–540CIDP11 (1:50)00NS
P050–74CIDP27 (1:400)000NS
P070–940000NS
P090–114CIDP27 (1:200)CIDP20 (1:200)HC10 (1:400)CIAP66 (1:200)NS
HC25 (1:100)
P0110–1340CIDP20 (1:200)HC10 (1:400)0NS
P0130–154CIDP39 (1:100)000NS
P0170–194CIDP39 (1:50)000NS
P0190–2140HC30 (1:200)CIAP64 (1:200)NS
P0210–2340CIDP32 (1:50)00NS
P0230–248CIDP12 (1:100)CIDP14 (1:100)0CIAP64 (1:100)NS
P21–2600HC31 (1:50)CIAP19 (1:100)NS
P220–450000NS
P240–6500HC24 (1:100)0NS
P260–850000NS
P280–105CIDP19 (1:50)00CIAP6 (1:1600)0.07*
CIDP52 (1:100)
CIDP36 (1:200)
CIDP15 (1:400)
P2100–125CIDP39 (1:200)CIDP3 (1:200)HC11 (1:200)0NS
P2120–132CIDP38 (1:400)0HC26 (1:800)CIAP53 (1:200)NS
PMP2220–45CIDP52 (1:100)00CIAP16 (1:50)NS
CIDP39 (1:100)
PMP2240–65CIDP41 (1:50)0HC40 (1:100)CIAP27 (1:200)NS
PMP22100–125CIDP39 (1:50)000NS
PMP22120–1450000NS
  • *Total CIDP versus HC and CIAP (χ2 test).

  • CIAP, chronic idiopathic axonal polyneuropathy; CIDP, chronic inflammatory demyelinating polyradiculoneuropathy; HC, healthy control; subjects’ code with positive tests (titre in parentheses): n, number; NS, not significant (χ2 test); nT, non-treated; T, treated.